Close Menu
Home › gonorrhea

gonorrhea

Nov 07, 2019

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

FIND also announced support for projects from Axxin and DNC Dx for point-of-care detection of sexually transmitted infections.  

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service. 

Oct 15, 2019

Enzo Biochem Fiscal Q4 Revenues Down 8 Percent

The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.

Sep 11, 2019

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

Premium

Antelope's founder said that being spun off by MyCartis gives his company the focus it needs to launch tests for use in homes and doctors' clinics.

Sep 06, 2019

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Premium

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

Aug 27, 2019

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Premium

The clearance of the Binx io CT/NG test marks a milestone for the Johns Hopkins University group that funds early-stage development of rapid STI testing.

Aug 21, 2019

MyCartis, Ghent University Spin Off Point-of-Care Testing Company Antelope Dx

MyCartis said that the new company, Antelope Dx, is developing a home test to diagnose Chlamydia trachomatis and Neisseria gonorrhea.

Aug 12, 2019

FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea

The firm said its platform provides sample-to-answer results for two of the most frequently tested sexually transmitted infections, enabling rapid testing and treatment.

Aug 05, 2019

SpeeDx Raises $15M in Equity Investment

The Australian molecular diagnostics firm will use the funds to accelerate commercial expansion in North America and global markets.

Jul 11, 2019

Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models

The latest NYS Department of Health approval expands the company's CT/NG testing to samples from multiple relevant body sites.

Pages

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.